Literature DB >> 27466423

Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.

Wenhui He1, Zhiliang Cao2, Fengfeng Mao3, Bijie Ren2, Yunfei Li2, Dan Li4, Huiyu Li2, Bo Peng5, Huan Yan2, Yonghe Qi2, Yinyan Sun2, Fengchao Wang2, Jianhua Sui6, Wenhui Li7.   

Abstract

UNLABELLED: Sodium taurocholate cotransporting polypeptide (NTCP) was identified as a functional receptor for hepatitis D virus (HDV) and its helper hepatitis B virus (HBV). In cultured cell lines, HDV infection through mouse NTCP is restricted by residues 84 to 87 of the receptor. This study shows that mice with these three amino acids altered their corresponding human residues (H84R, T86K, and S87N) in endogenous mouse NTCP support de novo HDV infection in vivo HDV infection was documented by the presence of replicative forms of HDV RNA and HDV proteins in liver cells at day 6 after viral inoculation. Monoclonal antibody specifically binding to the motif centered on K86 in NTCP partially inhibited HDV infection. These studies demonstrated specific interaction between the receptor and the viral envelopes in vivo and established a novel mouse model with minimal genetic manipulation for studying HDV infection. The model will also be useful for evaluating entry inhibitors against HDV and its helper HBV. IMPORTANCE: NTCP was identified as a functional receptor for both HDV and HBV in cell cultures. We recently showed that neonatal C57BL/6 transgenic (Tg) mice exogenously expressing human NTCP (hNTCP-Tg) in liver support transient HDV infection. In this study, we introduced alterations of three amino acids in the endogenous NTCP of FVB mice through genome editing. The mice with the humanized NTCP residues (H84R, T86K, and S87N) are susceptible to HDV infection, and the infection can be established in both neonatal and adult mice with this editing. We also developed a monoclonal antibody specifically targeting the region of NTCP centered on lysine residue 86, and it can differentiate the modified mouse NTCP from that of the wild type and partially inhibited HDV infection. These studies shed new light on NTCP-mediated HDV infection in vivo, and the NTCP-modified mice provide a useful animal model for studying HDV infection and evaluating antivirals against the infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27466423      PMCID: PMC5021397          DOI: 10.1128/JVI.00901-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Chronic hepatitis D at a standstill: where do we go from here?

Authors:  Alessia Ciancio; Mario Rizzetto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-10       Impact factor: 46.802

Review 2.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

3.  Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

Authors:  Marc Lütgehetmann; Lida V Mancke; Tassilo Volz; Martina Helbig; Lena Allweiss; Till Bornscheuer; Joerg M Pollok; Ansgar W Lohse; J Petersen; Stephan Urban; Maura Dandri
Journal:  Hepatology       Date:  2012-01-30       Impact factor: 17.425

4.  Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.

Authors:  Valérie Pasquetto; Stefan F Wieland; Susan L Uprichard; Marco Tripodi; Francis V Chisari
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep).

Authors:  G Fattovich; G Giustina; E Christensen; M Pantalena; I Zagni; G Realdi; S W Schalm
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.

Authors:  Katja Giersch; Martina Helbig; Tassilo Volz; Lena Allweiss; Lida V Mancke; Ansgar W Lohse; Susanne Polywka; Jörg M Pollok; Jörg Petersen; John Taylor; Maura Dandri; Marc Lütgehetmann
Journal:  J Hepatol       Date:  2013-11-23       Impact factor: 25.083

7.  TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas.

Authors:  C Jhappan; C Stahle; R N Harkins; N Fausto; G H Smith; G T Merlino
Journal:  Cell       Date:  1990-06-15       Impact factor: 41.582

8.  Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model.

Authors:  Karl-Dimiter Bissig; Tam T Le; Niels-Bjarne Woods; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

9.  Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.

Authors:  B Hagenbuch; P J Meier
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha.

Authors:  J C Wu; G Merlino; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

View more
  17 in total

1.  Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection.

Authors:  Benjamin Y Winer; Elham Shirvani-Dastgerdi; Yaron Bram; Julie Sellau; Benjamin E Low; Heath Johnson; Tiffany Huang; Gabriela Hrebikova; Brigitte Heller; Yael Sharon; Katja Giersch; Sherif Gerges; Kathleen Seneca; Mihai-Alexandru Pais; Angela S Frankel; Luis Chiriboga; John Cullen; Ronald G Nahass; Marc Lutgehetmann; Jared E Toettcher; Michael V Wiles; Robert E Schwartz; Alexander Ploss
Journal:  Sci Transl Med       Date:  2018-06-27       Impact factor: 17.956

2.  Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency.

Authors:  Fengfeng Mao; Teng Liu; Xinfeng Hou; Hanqing Zhao; Wenhui He; Cong Li; Zhiyi Jing; Jianhua Sui; Fengchao Wang; Xiaohui Liu; Jun Han; Christoph H Borchers; Jian-She Wang; Wenhui Li
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

3.  NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.

Authors:  Kento Fukano; Mizuki Oshima; Senko Tsukuda; Hideki Aizaki; Mio Ohki; Sam-Yong Park; Takaji Wakita; Kousho Wakae; Koichi Watashi; Masamichi Muramatsu
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

4.  Toward novel immunocompetent animal models for hepatitis B virus infection.

Authors:  Laurent Mailly; Mirjam B Zeisel; Thomas F Baumert
Journal:  Hepatology       Date:  2017-07-20       Impact factor: 17.298

5.  A novel toolbox for the in vitro assay of hepatitis D virus infection.

Authors:  Jing-Hua Zhao; Ya-Li Zhang; Tian-Ying Zhang; Lun-Zhi Yuan; Tong Cheng; Pei-Jer Chen; Quan Yuan; Ning-Shao Xia
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

6.  A potent human neutralizing antibody Fc-dependently reduces established HBV infections.

Authors:  Dan Li; Wenhui He; Ximing Liu; Sanduo Zheng; Yonghe Qi; Huiyu Li; Fengfeng Mao; Juan Liu; Yinyan Sun; Lijing Pan; Kaixin Du; Keqiong Ye; Wenhui Li; Jianhua Sui
Journal:  Elife       Date:  2017-09-26       Impact factor: 8.140

7.  TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection.

Authors:  Carla Usai; Sheila Maestro; Gracian Camps; Cristina Olague; Lester Suárez-Amaran; Africa Vales; Tomas Aragon; Mirja Hommel; Rafael Aldabe; Gloria Gonzalez-Aseguinolaza
Journal:  JHEP Rep       Date:  2020-03-10

Review 8.  In Vivo Model Systems for Hepatitis B Virus Research.

Authors:  Ana Maria Ortega-Prieto; Catherine Cherry; Harry Gunn; Marcus Dorner
Journal:  ACS Infect Dis       Date:  2019-01-08       Impact factor: 5.084

9.  Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.

Authors:  Ying Yan; Lena Allweiss; Danli Yang; Jingting Kang; Jianwen Wang; Xiangjun Qian; Ting Zhang; Hui Liu; Lu Wang; Shuhong Liu; Jianhua Sui; Xiangmei Chen; Maura Dandri; Jingmin Zhao; Fengmin Lu
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

Review 10.  Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.

Authors:  Florian A Lempp; Stephan Urban
Journal:  Viruses       Date:  2017-07-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.